Articles

Search Articles

Advanced search
Help

Catalogue

Articles

Databases

X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (629) 629
Publication (156) 156
Newsletter (90) 90
Newspaper Article (28) 28
Book Chapter (16) 16
Book Review (9) 9
Book / eBook (3) 3
Magazine Article (2) 2
Conference Proceeding (1) 1
Data Set (1) 1
Dissertation (1) 1
Government Document (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
lassa fever (409) 409
humans (395) 395
animals (369) 369
index medicus (316) 316
viruses (287) 287
virology (218) 218
lassa virus - immunology (213) 213
immunology (183) 183
infectious diseases (157) 157
lymphocytic choriomeningitis virus (148) 148
fever (145) 145
lassa virus (139) 139
health aspects (132) 132
virus diseases (131) 131
microbiology (130) 130
research (122) 122
mice (120) 120
hemorrhagic fever (115) 115
female (112) 112
male (103) 103
lassa fever - immunology (102) 102
vaccines (102) 102
arenavirus (100) 100
infection (99) 99
infections (94) 94
medicine (84) 84
lassa virus - genetics (80) 80
cell line (72) 72
viral vaccines - immunology (70) 70
lassa fever - epidemiology (68) 68
adult (67) 67
article (67) 67
research article (67) 67
ebola virus (66) 66
lassa fever - virology (63) 63
lassa virus - isolation & purification (62) 62
antibodies, viral - blood (61) 61
arenaviruses (61) 61
pathogenesis (61) 61
lassa fever - prevention & control (59) 59
epidemiology (58) 58
disease models, animal (56) 56
antibodies, viral - analysis (55) 55
hemorrhagic-fever (55) 55
infectious and parasitic diseases (54) 54
medical research (54) 54
cercopithecus aethiops (51) 51
vero cells (51) 51
guinea-pigs (50) 50
proteins (50) 50
public health (50) 50
analysis (49) 49
multidisciplinary sciences (48) 48
arenaviridae infections - virology (47) 47
disease (47) 47
guinea pigs (47) 47
antibodies (46) 46
lassa-virus (45) 45
dendritic cells (44) 44
lassa fever - diagnosis (43) 43
rna (43) 43
arenaviridae - immunology (42) 42
diagnosis (42) 42
medicine, experimental (42) 42
middle aged (42) 42
molecular sequence data (41) 41
arenaviridae infections - immunology (40) 40
ebola-virus (40) 40
enzyme-linked immunosorbent assay (39) 39
genetic aspects (39) 39
glycoproteins (39) 39
lassa (39) 39
replication (39) 39
virus (39) 39
antiviral agents (38) 38
argentine hemorrhagic-fever (37) 37
human dendritic cells (37) 37
immune response (37) 37
vaccination (37) 37
biology (36) 36
ebolavirus - immunology (36) 36
mice, inbred c57bl (36) 36
mortality (36) 36
parasitology (36) 36
virus replication (36) 36
west-africa (36) 36
hemorrhage (35) 35
lassa virus - pathogenicity (35) 35
lassa virus - physiology (35) 35
rodents (35) 35
adolescent (34) 34
antibodies, viral - immunology (33) 33
glycoprotein (33) 33
tropical medicine (33) 33
vaccine (33) 33
ebola (32) 32
fluorescent antibody technique (32) 32
immunization (32) 32
physiological aspects (32) 32
viral diseases (32) 32
more...
Library Location Library Location
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (716) 716
Russian (35) 35
French (5) 5
Dutch (1) 1
German (1) 1
Japanese (1) 1
Polish (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


1. Full Text Undiagnosed acute viral febrile illnesses, Sierra Leone
by Schoepp, Randal J and Rossi, Cynthia A and Khan, Sheik H and Goba, Augustine and Fair, Joseph N
Emerging Infectious Diseases, ISSN 1080-6040, 2014, Volume 20, Issue 7, pp. 1176 - 1182
Sierra Leone in West Africa is in a Lassa fever hyperendemic region that also includes Guinea and Liberia. Each year, suspected Lassa fever cases result in... 
ANTIBODIES | DIAGNOSIS | INFECTIOUS DISEASES | INFECTIONS | RIFT-VALLEY-FEVER | WEST-AFRICA | VIRUS | REEMERGENCE | MAURITANIA | IMMUNOLOGY | LASSA HEMORRHAGIC-FEVER | CONGO | Hemorrhagic Fevers, Viral - blood | Virus Diseases - blood | Virus Diseases - immunology | Hemorrhagic Fevers, Viral - immunology | Humans | Hemorrhagic Fevers, Viral - diagnosis | Arthropods - immunology | Virus Diseases - virology | Sierra Leone | Hemorrhagic Fever Virus, Crimean-Congo - immunology | Antibodies, Viral - blood | Immunoglobulin M - immunology | Lassa virus - immunology | Antigens, Viral - blood | Antigens, Viral - immunology | Animals | Immunoglobulin M - blood | Virus Diseases - diagnosis | Antibodies, Viral - immunology | Virus diseases | Evaluation | Care and treatment | Research | Medical case management | Medical geography | undiagnosed | viruses | serologic | hemorrhagic fever | Lassa virus | IgM | diagnostics | vector-borne infections | arthropod-borne | West Africa | febrile | immunodiagnostics | ELISA
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
2. Full Text Structure of the Lassa virus nucleoprotein reveals a dsRNA-specific 3' to 5' exonuclease activity essential for immune suppression
by Kathryn M. Hastie and Christopher R. Kimberlin and Michelle A. Zandonatti and Ian J. MacRae and Erica Ollmann Saphire and Robert A. Lamb
Proceedings of the National Academy of Sciences of the United States of America, ISSN 0027-8424, 2/2011, Volume 108, Issue 6, pp. 2396 - 2401
Lassa fever virus, a member of the family Arenaviridae, is a highly endemic category A pathogen that causes 300,000-500,000 infections per year in Western... 
Proteins | Lassa fever | Double stranded RNA | Lymphocytic choriomeningitis virus | Active sites | RNA | Nucleoproteins | DNA | Viruses | Arenavirus | Immunology | Structural biology | Virology | MECHANISM | RNA HELICASE | DNA-POLYMERASE-I | CRYSTAL-STRUCTURE | MULTIDISCIPLINARY SCIENCES | LYMPHOCYTIC CHORIOMENINGITIS VIRUS | MATRIX PROTEIN-Z | arenavirus | REPLICATION | INHIBITION | virology | DIFFRACTION | structural biology | immunology | FEVER | Nucleoproteins - chemistry | Protein Structure, Tertiary | Cell Line | Viral Proteins - chemistry | Exoribonucleases - immunology | Humans | Exoribonucleases - chemistry | Viral Proteins - immunology | Crystallography, X-Ray | Immunity, Innate | Lassa virus - immunology | RNA, Double-Stranded - immunology | Lassa virus - enzymology | RNA, Double-Stranded - chemistry | Interferon Regulatory Factor-3 - immunology | Nucleoproteins - immunology | Physiological aspects | Exonucleases | Genetic aspects | Arenaviruses | Research | Immune system | Biological Sciences
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
3. Full Text Most neutralizing human monoclonal antibodies target novel epitopes requiring both Lassa virus glycoprotein subunits
by Robinson, James E and Hastie, Kathryn M and Cross, Robert W and Yenni, Rachael E and Elliott, Deborah H and Rouelle, Julie A and Kannadka, Chandrika B and Smira, Ashley A and Garry, Courtney E and Bradley, Benjamin T and Yu, Haini and Shaffer, Jeffrey G and Boisen, Matt L and Hartnett, Jessica N and Zandonatti, Michelle A and Rowland, Megan M and Heinrich, Megan L and Martinez-Sobrido, Luis and Cheng, Benson and De La Torre, Juan C and Andersen, Kristian G and Goba, Augustine and Momoh, Mambu and Fullah, Mohamed and Gbakie, Michael and Kanneh, Lansana and Koroma, Veronica J and Fonnie, Richard and Jalloh, Simbirie C and Kargbo, Brima and Vandi, Mohamed A and Gbetuwa, Momoh and Ikponmwosa, Odia and Asogun, Danny A and Okokhere, Peter O and Follarin, Onikepe A and Schieffelin, John S and Pitts, Kelly R and Geisbert, Joan B and Kulakoski, Peter C and Wilson, Russell B and Happi, Christian T and Sabeti, Pardis C and Gevao, Sahr M and Khan, S. Humarr and Grant, Donald S and Geisbert, Thomas W and Saphire, Erica Ollmann and Branco, Luis M and Garry, Robert F
Nature Communications, ISSN 2041-1723, 05/2016, Volume 7, Issue 1, p. 11544
Lassa fever is a severe multisystem disease that often has haemorrhagic manifestations. The epitopes of the Lassa virus (LASV) surface glycoproteins recognized... 
THERAPY | B-CELL | HEMORRHAGIC-FEVER | STRUCTURAL BASIS | MULTIDISCIPLINARY SCIENCES | ENVELOPE GLYCOPROTEIN | PROTEINS | TYPE-1 | LYMPHOCYTIC CHORIOMENINGITIS VIRUS | QUATERNARY | PEPTIDE | Antibody Specificity | Epitope Mapping | Sequence Deletion | Viral Envelope Proteins - genetics | Mutagenesis, Site-Directed | Humans | Lassa Fever - prevention & control | Lassa virus - genetics | Models, Molecular | Antigens, Viral - chemistry | Antigens, Viral - genetics | Epitopes - genetics | Lassa virus - immunology | Arenavirus - immunology | Cross Reactions | Epitopes - immunology | Antigens, Viral - immunology | Antibodies, Neutralizing - immunology | Lassa Fever - immunology | Viral Envelope Proteins - chemistry | Antibodies, Viral - immunology | Viral Envelope Proteins - immunology | Epitopes - chemistry | Antibodies, Monoclonal - immunology
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
4. Full Text Immunobiology of Ebola and Lassa virus infections
by Prescott, Joseph B and Marzi, Andrea and Safronetz, David and Robertson, Shelly J and Feldmann, Heinz and Best, Sonja M
Nature Reviews Immunology, ISSN 1474-1733, 03/2017, Volume 17, Issue 3, pp. 195 - 207
Two of the most important contemporary emerging viruses that affect human health in Africa are Ebola virus (EBOV) and Lassa virus (LASV). The 2013-2016 West... 
NONHUMAN-PRIMATES | DOUBLE-STRANDED-RNA | HUMAN DENDRITIC CELLS | WEST-AFRICA | HEMORRHAGIC-FEVER | INTERFERON ANTAGONISM | NEUTRALIZING ANTIBODY | IMMUNE-RESPONSES | SIERRA-LEONE | VP35 PROTEIN | IMMUNOLOGY | Hemorrhagic Fever, Ebola - immunology | Humans | Lassa Fever - immunology | Ebolavirus - immunology | Lassa virus - immunology | Physiological aspects | Ebola virus infections | Development and progression | Lassa fever | Immune response
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
5. Full Text Vesicular stomatitis virus–based vaccines against lassa and ebola viruses
by Marzi, Andrea and Feldmann, Friederike and Geisbert, Thomas W and Feldmann, Heinz and Safronetz, David
Emerging Infectious Diseases, ISSN 1080-6040, 2015, Volume 21, Issue 2, pp. 305 - 307
We demonstrated that previous vaccination with a vesicular stomatitis virus (VSV) based Lassa virus vaccine does not alter protective efficacy of subsequent... 
ANTIBODIES | CHALLENGE | INFECTIOUS DISEASES | PROTECTS NONHUMAN-PRIMATES | DISEASE | GLYCOPROTEINS | IMMUNOLOGY | Hemorrhagic Fever, Ebola - prevention & control | Humans | Lassa Fever - prevention & control | Vaccination | Macaca fascicularis | Vaccines, Synthetic - immunology | Ebolavirus - immunology | Lassa virus - immunology | Lassa Fever - mortality | Viral Vaccines - administration & dosage | Animals | Hemorrhagic Fever, Ebola - mortality | Genetic Vectors | Viral Vaccines - immunology | Vesicular stomatitis Indiana virus - immunology | Disease Models, Animal | Ebola virus | Stomatitis | Hemorrhagic fever | Vaccines | Health aspects | virus-based vaccines | viruses | Expedited | vaccines | vesicular stomatitis virus | Dispatch | nonhuman primates | Lassa virus | pre-existing immunity | West Africa | Vesicular Stomatitis Virus–based Vaccines against Lassa and Ebola Viruses | VSV | viral hemorrhagic fever | sequential vaccination
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
6. Full Text Structural basis for antibody-mediated neutralization of Lassa virus
by Hastie, Kathryn M and Zandonatti, Michelle A and Kleinfelter, Lara M and Heinrich, Megan L and Rowland, Megan M and Chandran, Kartik and Branco, Luis M and Robinson, James E and Garry, Robert F and Saphire, Erica Ollmann
Science, ISSN 0036-8075, 06/2017, Volume 356, Issue 6341, pp. 923 - 928
The arenavirus Lassa causes severe hemorrhagic fever and a significant disease burden in West Africa every year. The glycoprotein, GPC, is the sole antigen... 
ALPHA-DYSTROGLYCAN | ENTRY | CRYSTAL-STRUCTURE | MULTIDISCIPLINARY SCIENCES | ARENAVIRUS ENVELOPE GLYCOPROTEIN | CELLULAR RECEPTOR | HUMAN MONOCLONAL-ANTIBODIES | LYMPHOCYTIC CHORIOMENINGITIS VIRUS | BINDING | STABLE SIGNAL PEPTIDE | HEMORRHAGIC-FEVER ARENAVIRUSES | Antibodies, Viral - metabolism | Humans | Protein Multimerization | Antibodies, Neutralizing - metabolism | Crystallization | Models, Molecular | Lassa Fever - virology | Lassa virus - immunology | Virus Internalization | Lassa virus - physiology | Antibodies, Neutralizing - chemistry | Lassa Fever - immunology | Viral Envelope Proteins - chemistry | Antibodies, Viral - chemistry | Protein Structure, Quaternary | Viral Envelope Proteins - metabolism | Protein Binding | Lassa virus - chemistry | Protein Conformation | Epitopes - chemistry | Protein Stability | Hydrogen-Ion Concentration | Prevention | Health aspects | Arenaviruses | Hemorrhagic fever | High resolution | Viruses | Biochemistry | Hemorrhagic disease | Design analysis | Hemorrhage | Monomers | Receptors | pH | Inhibition | Assembly | Public health | Crystal structure | Binding | RNA viruses | Antigens | Biochemical analysis | Glycoprotein | Glycoproteins | Fatal | Ribonucleic acid--RNA | Fever | Anchors | Lassa fever | Neutralizing | Neutralization | Antibodies | Vaccines
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
7. Full Text A bioinformatics tool for epitope-based vaccine design that accounts for human ethnic diversity: Application to emerging infectious diseases
by Oyarzun, Patricio and Ellis, Jonathan J and Gonzalez-Galarza, Faviel F and Jones, Andrew R and Middleton, Derek and Boden, Mikael and Kobe, Bostjan
Vaccine, ISSN 0264-410X, 2015, Volume 33, Issue 10, pp. 1267 - 1273
Abstract Background Peptide vaccination based on multiple T-cell epitopes can be used to target well-defined ethnic populations. Because the response to T-cell... 
Allergy and Immunology | Lassa, Nipah and Hendra viruses | MHC (HLA) class II proteins | Immunodominance | Multi-epitope peptide vaccination | Emerging infectious diseases | MEDICINE, RESEARCH & EXPERIMENTAL | HLA CLASS-II | PROTEIN | G-GLYCOPROTEIN | IMMUNOLOGY | SUBUNIT VACCINE | VIRAL-INFECTION | COMPREHENSIVE ANALYSIS | NIPAH VIRUS-INFECTION | HENDRA-VIRUS | LASSA FEVER | T-CELLS | Henipavirus Infections - immunology | Humans | Lassa Fever - prevention & control | AIDS Vaccines - immunology | Computational Biology | Histocompatibility Antigens Class I - immunology | Epitopes, T-Lymphocyte - genetics | Histocompatibility Antigens Class I - genetics | Vaccines, Subunit - immunology | Continental Population Groups - genetics | Nipah Virus - immunology | Hendra Virus - immunology | Lassa virus - immunology | CD4-Positive T-Lymphocytes - immunology | Henipavirus Infections - prevention & control | Glycoproteins - immunology | HIV-1 - immunology | Histocompatibility Antigens Class II - immunology | Lassa Fever - immunology | Drug Design | Viral Envelope Proteins - immunology | Epitopes, T-Lymphocyte - immunology | Histocompatibility Antigens Class II - genetics | gag Gene Products, Human Immunodeficiency Virus - immunology | Proteins | Multiculturalism | Vaccines | T cells | Vaccination | Antigenic determinants | Bioinformatics | Multiculturalism & pluralism | Mortality
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
8. Full Text Plasmacytoid Dendritic Cells Are Productively Infected and Activated through TLR-7 Early after Arenavirus Infection
by Macal, Mónica and Lewis, Gavin M and Kunz, Stefan and Flavell, Richard and Harker, James A and Zúñiga, Elina I
Cell Host & Microbe, ISSN 1931-3128, 06/2012, Volume 11, Issue 6, pp. 617 - 630
The antiviral response is largely mediated by dendritic cells (DCs), including conventional (c) DCs that function as antigen-presenting cells, and plasmacytoid... 
INTERFERON-ALPHA/BETA | LASSA VIRUS | PERSISTENCE | MICROBIOLOGY | CHRONIC VIRAL-INFECTION | LYMPHOCYTIC CHORIOMENINGITIS VIRUS | RESPONSES | ANTIVIRAL DEFENSE | HIV-INFECTION | VIROLOGY | TYPE-1 IFN | IN-VIVO | PARASITOLOGY | Toll-Like Receptor 7 - metabolism | Arenaviridae Infections - virology | Membrane Glycoproteins - metabolism | Receptors, Virus - metabolism | Dendritic Cells - immunology | Mice, Inbred C57BL | Cytokines - secretion | Lassa virus - pathogenicity | Lassa virus - physiology | Animals | Lymphocytic choriomeningitis virus - pathogenicity | Toll-Like Receptor 7 - immunology | Virus Attachment | Receptors, Virus - immunology | Lymphocytic choriomeningitis virus - physiology | Mice | Membrane Glycoproteins - immunology | Dendritic Cells - virology | Arenaviridae Infections - immunology | Disease Models, Animal | Antiviral agents | Medical colleges | Dendritic cells | Health aspects | type I interferon | lymphocytic choriomeningitis virus (LCMV) | Lassa Fever virus (LASV) | arenavirus | plasmacytoid dendritic cells | chronic viral infection | innate | toll like receptor-7 | dendritic cell | interleukin-12
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
9. Full Text Cutting Edge: Impairment of Dendritic Cells and Adaptive Immunity by Ebola and Lassa Viruses
by Mahanty, Siddhartha and Hutchinson, Karen and Agarwal, Sudhanshu and Mcrae, Michael and Rollin, Pierre E and Pulendran, Bali
The Journal of Immunology, ISSN 0022-1767, 03/2003, Volume 170, Issue 6, pp. 2797 - 2801
Acute infection of humans with Ebola and Lassa viruses, two principal etiologic agents of hemorrhagic fevers, often results in a paradoxical pattern of immune... 
T-Lymphocyte Subsets - immunology | Dendritic Cells - immunology | Humans | Cells, Cultured | Ebolavirus - pathogenicity | Immunity, Active - immunology | Lassa Fever - virology | Monocytes - immunology | Antigen Presentation - immunology | Antigen-Presenting Cells - immunology | Antigen-Presenting Cells - virology | Ebolavirus - immunology | Lassa virus - immunology | T-Lymphocyte Subsets - virology | Lassa virus - pathogenicity | Cell Differentiation - immunology | Monocytes - virology | Cell Division - immunology | Hemorrhagic Fever, Ebola - virology | Lassa Fever - immunology | Hemorrhagic Fever, Ebola - immunology | Dendritic Cells - virology
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
10. Full Text A vaccine platform against arenaviruses based on a recombinant hyperattenuated Mopeia virus expressing heterologous glycoproteins
by Carnec, Xavier and Mateo, Mathieu and Page, Audrey and Reynard, Stéphanie and Hortion, Jimmy and Picard, Caroline and Yekwa, Elsie and Barrot, Laura and Barron, Stéphane and Vallve, Audrey and Raoul, Hervé and Carbonnelle, Caroline and Ferron, François and Baize, Sylvain
Journal of Virology, ISSN 0022-538X, 06/2018, Volume 92, Issue 12, pp. e02230 - 17
Several Old World and New World arenaviruses are responsible for severe endemic and epidemic hemorrhagic fevers, whereas other members of the Arenaviridae... 
Innate immunity | Lassa fever | Viral hemorrhagic fevers | Livevector vaccines | Arenavirus | HUMAN DENDRITIC CELLS | LASSA VIRUS | LIVE-ATTENUATED VACCINES | RHESUS-MONKEYS | I INTERFERON RESPONSE | ARGENTINE HEMORRHAGIC-FEVER | LYMPHOCYTIC CHORIOMENINGITIS VIRUS | MASTOMYS-NATALENSIS | arenavirus | VIROLOGY | innate immunity | viral hemorrhagic fevers | NUCLEOPROTEIN | CODON DEOPTIMIZATION | live-vector vaccines | Lassa Fever/prevention & control | Humans | Vaccination | Macaca fascicularis | Cercopithecus aethiops | Hemorrhagic Fevers, Viral/pathology | Life Sciences | Arenaviridae/immunology | HEK293 Cells | Viral Vaccines/immunology | Biomolecules | Arenaviridae/genetics | Interferon Type I/immunology | Lassa virus/immunology | Monkey Diseases/prevention & control | Vero Cells | Monkey Diseases/immunology | Lassa Fever/immunology | Cell Line | Cricetinae | Vaccines, Attenuated/immunology | Biochemistry, Molecular Biology | Lassa Fever/virology | Hemorrhagic Fevers, Viral/virology | Animals | Hemorrhagic Fevers, Viral/transmission | Exoribonucleases/metabolism | Hemorrhagic Fevers, Viral/immunology | Monkey Diseases/virology
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
11. Full Text Structures of arenaviral nucleoproteins with triphosphate dsRNA reveal a unique mechanism of immune suppression
by Jiang, Xue and Huang, Qinfeng and Wang, Wenjian and Dong, Haohao and Ly, Hinh and Liang, Yuying and Dong, Changjiang
Journal of Biological Chemistry, ISSN 0021-9258, 06/2013, Volume 288, Issue 23, pp. 16949 - 16959
A hallmark of severe Lassa fever is the generalized immune suppression, the mechanism of which is poorly understood. Lassa virus (LASV) nucleoprotein (NP) is... 
PATHOGENESIS | SITE | VIRUS | RNA | AUTOIMMUNITY | CRYSTAL-STRUCTURE | DNA | TREX1 | BIOCHEMISTRY & MOLECULAR BIOLOGY | RIG-I | BINDING | Nucleoproteins - chemistry | Exoribonucleases - genetics | Humans | Nucleoproteins - genetics | Exoribonucleases - chemistry | Lassa Fever - genetics | Viral Proteins - immunology | Arenaviruses, New World - genetics | Crystallography, X-Ray | Interferon Type I - immunology | Arenaviruses, New World - immunology | Viral Proteins - metabolism | Arenaviruses, New World - enzymology | RNA, Viral - genetics | Lassa Fever - immunology | Interferon Type I - metabolism | RNA, Double-Stranded - metabolism | RNA, Viral - metabolism | Lassa virus - enzymology | RNA, Double-Stranded - chemistry | Nucleoproteins - immunology | Protein Structure, Tertiary | Cell Line | Viral Proteins - chemistry | Exoribonucleases - immunology | Immune Tolerance | Lassa virus - genetics | Viral Proteins - genetics | Lassa Fever - metabolism | Lassa virus - immunology | RNA, Viral - chemistry | Nucleoproteins - metabolism | RNA, Double-Stranded - genetics | RNA, Double-Stranded - immunology | RNA, Viral - immunology | Exoribonucleases - metabolism | Molecular Bases of Disease | 3′-5′ Exoribonuclease | Immunosuppression | Viral Protein | Immune Evasion | Protein-nucleic Acid Interaction | Nucleic Acid Enzymology | Protein Structure | Type I Interferons | Lassa Fever Virus | Tacaribe Virus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
12. Full Text Safety, immunogenicity, and efficacy of the ML29 reassortant vaccine for Lassa fever in small non-human primates
by Lukashevich, Igor S and Carrion, Ricardo and Salvato, Maria S and Mansfield, Keith and Brasky, Kathleen and Zapata, Juan and Cairo, Cristiana and Goicochea, Marco and Hoosien, Gia E and Ticer, Anysha and Bryant, Joseph and Davis, Harry and Hammamieh, Rasha and Mayda, Maria and Jett, Marti and Patterson, Jean
Vaccine, ISSN 0264-410X, 2008, Volume 26, Issue 41, pp. 5246 - 5254
Abstract A single injection of ML29 reassortant vaccine for Lassa fever induces low, transient viremia, and low or moderate levels of ML29 replication in... 
Allergy and Immunology | Lassa fever | Vaccine | Arenaviruses | Protection | MEDICINE, RESEARCH & EXPERIMENTAL | MOPEIA VIRUSES | RNA | GUINEA-PIGS | IMMUNOLOGY | LYMPHOCYTIC CHORIOMENINGITIS VIRUS | LIVER PATHOLOGY | GENE | NIGERIAN STRAIN | INFECTION | NUCLEOTIDE-SEQUENCE | RHESUS MACAQUES | Gene Expression Regulation - immunology | Humans | Lassa Fever - prevention & control | Cercopithecus aethiops | Lassa virus - genetics | Reassortant Viruses - genetics | Lipopolysaccharide Receptors - immunology | Male | Lassa virus - immunology | Lassa virus - isolation & purification | Immunity, Cellular - immunology | Reassortant Viruses - immunology | Animals | Lassa Fever - pathology | Lassa Fever - immunology | Leukocytes, Mononuclear - immunology | CD3 Complex - immunology | Survival Analysis | Female | T-Lymphocytes - immunology | Viremia - immunology | Safety | Callithrix - immunology | Vero Cells | Primates | Vaccines | Proteins | Studies | Enzymes | Biomedical research | Viruses | Genomes | Histology | RNA polymerase | Kinases | Monkeys & apes | Lassa Fever
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights